| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/18/2006 | EP1616883A2 Antibodies against VLA-4 |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616579A1 CD40 binding molecules and CTL peptides for treating tumors |
| 01/18/2006 | EP1616576A1 Specific nad(p)h oxidase inhibitor |
| 01/18/2006 | EP1616575A1 Method for treating inflammation |
| 01/18/2006 | EP1616574A1 Receptor specific transepithelial transport of therapeutics |
| 01/18/2006 | EP1616568A2 GSK-3 inhibitors and CDK inhibitors as anti-glaucoma agents |
| 01/18/2006 | EP1616567A1 Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts |
| 01/18/2006 | EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases |
| 01/18/2006 | EP1616562A1 Novel preparation and administration form comprising an acid-labile active compound |
| 01/18/2006 | EP1616561A1 Antidiabetic preparation for oral administration |
| 01/18/2006 | EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 01/18/2006 | EP1615880A2 Preparation and purification of synthetic capsaicin |
| 01/18/2006 | EP1615698A2 New amide derivatives and pharmaceutical use thereof |
| 01/18/2006 | EP1615697A2 New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof |
| 01/18/2006 | EP1615667A2 Combinations of an 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist |
| 01/18/2006 | EP1615666A2 Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
| 01/18/2006 | EP1615665A2 Delivery of immune response modifier compounds |
| 01/18/2006 | EP1615647A2 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/18/2006 | EP1615646A1 Pharmaceutical formulations containing methylnaltrexone |
| 01/18/2006 | EP1615642A1 Combination of paroxetine and 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)- (2s-phenyl-piperidin-3s-yl)-amine for treatment of depression and/or anxiety |
| 01/18/2006 | EP1615641A1 Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo 1,2-a -pyrazin-2-yl)-piperidine-1-carboxylic acid 1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl -methylamide for treatment of depression/anxiety |
| 01/18/2006 | EP1615638A1 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy |
| 01/18/2006 | EP1615621A2 Compositions for delivery of drug combinations |
| 01/18/2006 | EP1615615A2 Pharmaceutical products |
| 01/18/2006 | EP1512016B1 Screening method and anti-tumor drug candidate obtained therefrom |
| 01/18/2006 | EP1404672B1 Tyrosine kinase inhibitors |
| 01/18/2006 | EP1404347B1 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 01/18/2006 | EP1286663B1 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | EP1169475B1 Diagnosis of a person's risk for developing diabetic retinopathy |
| 01/18/2006 | EP0998274B1 Microdose therapy of vascular conditions by no donors |
| 01/18/2006 | EP0828492B1 Medicaments for preventing intervention-associated stenosis following non-bypass, invasive interventions |
| 01/18/2006 | EP0819004A4 Pharmaceutical composition containing proton pump inhibitors |
| 01/18/2006 | EP0735895B1 A method for preventing or controlling cataract |
| 01/18/2006 | CN1723059A Insulin receptor activators for the treatment of human body metabolic disorder resulting from treatment of HIV infection with HIV protease inhibitors |
| 01/18/2006 | CN1723052A Enhanced parmacokinetic profile of hydrophobic dopamine agonists administered to the dermis |
| 01/18/2006 | CN1723040A Amended recombinant cells (ARCs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants |
| 01/18/2006 | CN1723037A Methods and compositions for promoting the maturation of monocytes |
| 01/18/2006 | CN1723027A Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/18/2006 | CN1723025A Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV |
| 01/18/2006 | CN1723015A Fatigue reducing agent |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1720995A The treatment of respiratory diseases |
| 01/18/2006 | CN1720994A Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 01/18/2006 | CN1720993A Stem cell preparation for treating Alzheimer disease and its preparation process |
| 01/18/2006 | CN1720992A Treatment for central nervous system lymphoma |
| 01/18/2006 | CN1720941A Compound medicinal preparation with clopidogrel and red rice extracts and application thereof |
| 01/18/2006 | CN1720916A Rapidly decomposing administrable form for releasing active ingredient in oral cavity or bodily cavity |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1236817C Novel mixtures of microbial enzymes |
| 01/18/2006 | CN1236816C Tissue volume reduction |
| 01/18/2006 | CN1236815C Application of integrin antagonists in preparation of medicine for treating multiple myeloma and myeloma-induced bone resorption |
| 01/18/2006 | CN1236813C Self-emulsifying compositions for drugs poorly soluble in water |
| 01/18/2006 | CN1236773C Preparation for analgesia and anesthesia or treating drug dependence |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/18/2006 | CN1236764C Method for preparing a composition |
| 01/18/2006 | CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 01/18/2006 | CN1236759C New pharmaceutical preparation for pain management |
| 01/18/2006 | CN1236758C Slow-releasing injection contg. hydrocastor oil/medicine (for treatment) solid dispersion microparticle |
| 01/18/2006 | CN1236757C Slimming composition contg. substance inducing IL-6 production |
| 01/17/2006 | US6987129 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc. |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/17/2006 | US6987103 Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents |
| 01/17/2006 | US6987102 Methods to mobilize progenitor/stem cells |
| 01/17/2006 | US6987098 Health supplement |
| 01/17/2006 | US6987095 Fish feed with increased nucleotide content |
| 01/17/2006 | US6987021 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 01/17/2006 | US6987014 Isolated nucleic acid molecules encoding human drug metabolizing proteins |
| 01/17/2006 | US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders |
| 01/17/2006 | US6987001 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 01/17/2006 | US6986901 Gastrointestinal compositions |
| 01/17/2006 | US6986894 Methods for the treatment of coagulation disorders with lipoprotein associated coagulation inhibitor (LACI) |
| 01/17/2006 | US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 01/17/2006 | US6986346 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 01/17/2006 | CA2346171C Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid |
| 01/17/2006 | CA2338792C Rapidly disintegrable solid preparation |
| 01/12/2006 | WO2006004633A2 A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 01/12/2006 | WO2006004588A2 Immunodynamic complexes and methods for using and preparing such complexes |
| 01/12/2006 | WO2006004194A1 METHOD OF SCREENING REMEDY FOR ALZHEIMER’S DISEASE TARGETING TGF β2 |
| 01/12/2006 | WO2006004173A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | WO2005105079A3 Novel imidazoles |
| 01/12/2006 | WO2005097088A3 Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure |
| 01/12/2006 | WO2005087206A3 Cancer therapy comprising a nuclear receptor ligand and a hdac inhibitor |
| 01/12/2006 | WO2005018574A3 Immunostimulatory combinations and treatments |
| 01/12/2006 | WO2004080401A3 Oral insulin therapies and protocol |
| 01/12/2006 | WO2004045497A3 Cd26-based therapies for cancers and immune disease |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009514 Method for treating obesity |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009512 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 01/12/2006 | US20060009503 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 01/12/2006 | US20060009502 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 01/12/2006 | US20060009497 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |